CD93 and neoplasm: Furthermore, after grouping STAD patients based on their tumor stage, we found that the gene expression of CD93 was comparable between normal tissues and stage one STAD tissues, which were significantly lower than that in STAD tissues with higher stages (range from stage two to four).